世界のがんスクリーニング市場見通し2027

◆英語タイトル:Global Cancer Screening Market Outlook 2027
◆商品コード:NEST20JN030
◆発行会社(リサーチ会社):Research Nester
◆発行日:2020年5月
◆ページ数:554
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,150 ⇒換算¥431,600見積依頼/購入/質問フォーム
Site License(同一拠点閲覧用)USD5,150 ⇒換算¥535,600見積依頼/購入/質問フォーム
Enterprisewide License(同一法人閲覧用)USD7,150 ⇒換算¥743,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はResearch Nester社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Research Nester社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

Cancer Screening Market Analysis – 2019-2027
According to the World Health Organization, the global cancer burden is estimated to have risen to 18.1 million new cases and 9.6 million deaths in 2018.Cancer screening tests are diagnostic procedures that are done in order to identify cancer in the body and therefore reduce the number of people who develop cancer or reach the later stages of cancer where it becomes untreatable. These tests can help to detect cancer at its early stages, where it may be easier to treat. The market for cancer screening is anticipated to grow at a significant CAGR of around 9.67% over the forecast period, i.e., 2020-2027.
The market is segmented by diagnostic methods, by cancer, by end user and by region. Based on the diagnostic methods, the market for cancer screening is segmented into genetic tests, instrument based tests and platform based tests. Out of these, the segment for instrument based tests is is anticipated to attain a market size of around USD 177,978 million by the year 2027 and is projected to grow with a significant CAGR over the forecast period. This segment is further divided into imaging tests, endoscopy procedures and biopsy, out of which, the segment for imaging tests is predicted to hold the leading share in the market on account of rising demand for minimally invasive procedures globally.
On the basis of region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. The market in North America is anticipated to hold the leading share over the forecast period. The growth in the region can be attributed to the increase in investments towards healthcare from government and private entities in order to maintain the highest quality of care offered in healthcare facilities. Further, the market in Asia Pacific region is anticipated to grow with the highest CAGR of 11.12% over the forecast period on account of demand for new and improved technology and treatment methods from China. With the rising availability of advanced healthcare in Asia Pacific along with growing number of manufacturers investing in countries such as China, Japan, & India, the demand for cancer screening products in this region is estimated to witness a rapid growth in the coming years.
Some of the key industry leaders in the global cancer screening market are Siemens Healthineers AG, GE Healthcare, Abbott, F. Hoffmann-La Roche Ltd., Olympus Corporation, FUJIFILM Corporation, Agilent Technologies, Inc. and Thermo Fisher Scientific.

【レポートの目次】

Global Cancer Screening Market
1. Introduction
1.1. Market Definition
1.2. Market Segmentation
1.3. Product Overview
2. Assumptions And Acronyms
3. Research Methodology
4. Executive Summary – Global Cancer Screening Market
5. Regulatory Landscape
6. Epidemiology Analysis
7. Market Dynamics
7.1. Growth Drivers
7.2. Restraints
7.3. Key Trends
7.4. Opportunities
8. Key Manufacturers
9. Recent Technological Advancements
10. Cancer Screening Market – Risk Analysis
10.1. Demand Risk Analysis
10.2. Supply Risk Analysis
11. Global Cancer Screening Market Outlook

11.1. Market Size And Forecast, 2019-2027
11.1.1. By Value (Usd Million)
11.2. Global Cancer Screening Market Segmentation, 2019-2027
· By Diagnostic Method
V Genetic Tests: Brca Tests, Her2 Tests, Ca-125 Test Kras Mutation Tests, Alpha-Fetoprotein (Afp) Test, Ca-19 Radioimmunoassay Tests, Immunoglobulins Test, Chromogranin A (Cga) Tests, Others, 2019-2027f (Usd Million)
V Instrument Based Tests: Imaging Tests, Endoscopy Procedures & Biopsy, 2019-2027f (Usd Million)
Ø Imaging Tests: X-Rays, Computed Tomography (Ct), Magnetic Resonance Imaging (Mri), Positron Emission Tomography, Ultrasound & Mammography, 2019-2027f (Usd Million)
Ø Endoscopy Procedures: Bronchoscopy, Colonoscopy, Cystoscopy, Laparoscopy, Thoracoscopy & Others, 2019-2027f (Usd Million)
Ø Biopsy: Needle Biopsy, Bone Marrow Biopsy, Punch Biopsy, Skin Biopsy, Shave Biopsy & Others, 2019-2027f (Usd Million)
V Platform Based Tests: Immunohistochemistry, Next-Generation Sequencing, Pcr, Microarrays, Flow Cytometry, In-Situ Hybridization & Others, Chromogranin A (Cga) Tests & Others, 2019-2027f (Usd Million)
· By Type Of Cancer
V Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Blood Cancer, Liver Cancer, Pancreatic Cancer, Skin Cancer, Cervical Cancer & Others, 2019-2027f (Usd Million)
· By End User
V Hospitals, Oncology Clinics, Diagnostic Centers And Others, 2019-2027f (Usd Million)
11.3. Global Cancer Screening Market Segmentation- By Region
§ North America Cancer Screening Market, 2019-2027f (Usd Million)
Ø Market Overview
Ø Market Size, 2019-2027f (Usd Million)
Ø Market Segmentation
· By Diagnostic Method
· By Type Of Cancer
· By End User
· By Country
§ Europe Cancer Screening Market, 2019-2027f (Usd Million)
Ø Market Overview
Ø Market Size, 2019-2027f (Usd Million)
Ø Market Segmentation
· By Diagnostic Method
· By Type Of Cancer
· By End User
· By Country
§ Asia Pacific Cancer Screening Market, 2019-2027f (Usd Million)
Ø Market Overview
Ø Market Size, 2019-2027f (Usd Million)
Ø Market Segmentation
· By Diagnostic Method
· By Type Of Cancer
· By End User
· By Country
§ Latin America Cancer Screening Market, 2019-2027f (Usd Million)
Ø Market Overview
Ø Market Size, 2019-2027f (Usd Million)
Ø Market Segmentation
· By Diagnostic Method
· By Type Of Cancer
· By End User
· By Country
§ Middle East & Africa Cancer Screening Market, 2019-2027f (Usd Million)
Ø Market Overview
Ø Market Size, 2019-2027f (Usd Million)
Ø Market Segmentation
· By Diagnostic Method
· By Type Of Cancer
· By End User
· By Country
12. Competitive Structure
12.1. Detailed Overview
12.2. Assessment Of Key Product Offerings
12.3. Analysis Of Growth Strategies
12.4. Key Collaborations And Joint Ventures
12.5. Key Mergers And Acquisitions
12.6. Recent News And Developments
12.7. Key Clients And Partners
12.8. Exhaustive Analysis On Key Financial Indicators
12.9. Company Profiles Of Global Cancer Screening Market
12.9.1. Roche
12.9.2. Abbott
12.9.3. Fujifilm
12.9.4. Siemens Healthineers
12.9.5. Ge Healthcare
12.9.6. Thermo Fisher Scientific
12.9.7. Olympus Corporation
12.9.8. Agilent
12.9.9. Other Market Players
13. Strategic Recommendations



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界のがんスクリーニング市場見通し2027]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆